Title : Air-flow limitation in myasthenia gravis. The effect of acetylcholinesterase inhibitor therapy on air-flow limitation.

Pub. Date : 1983 Oct

PMID : 6226224






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Thus, acetylcholinesterase inhibitor therapy in subjects with myasthenia gravis with airflow limitation led to significant increase in airways resistance that could be completely reversed by the inhalation of the muscarinic receptor blocker ipratropium bromide. Ipratropium acetylcholinesterase (Cartwright blood group) Homo sapiens